Solid Biosciences Inc. Gains 41.78%
Tue, Feb 23, 2021 at 05:30 PM
Solid Biosciences Inc. (SLDB:NASDAQ) soared at $9.74, a gain of 41.8%. On Mon 22 Feb 21, SLDB:NASDAQ touched a New 2-Week Low of $6.87. The stock got featured on our News Catalysts scanner on Wed 17 Feb 21 at 08:31 AM in the 'MISCELLANEOUS' category. From Mon 08 Feb 21, the stock recorded 22.22% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Solid Biosciences Inc. (SLDB:NASDAQ)
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Top 10 Gainers:
- Solid Biosciences Inc. (SLDB:NASDAQ), 41.78%
- TimkenSteel Corporation (TMST:NYSE), 26.83%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 24.05%
- Ardagh Group S.A. (ARD:NYSE), 21.52%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 20.22%
- Friedman Industries, Incorporated (FRD:NYSEMKT), 20.11%
- Savara Inc. (SVRA:NASDAQ), 19.08%
- LNSR (LNSR:NASDAQ), 18.6%
- The L.S. Starrett Company (SCX:NYSE), 18.17%
- AMC Entertainment Holdings, Inc. (AMC:NYSE), 17.56%